Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
Acute coronary syndrome (ACS) is one of the most common leading global causes of mortality, encompassing ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina (UA). Percutaneous coronary intervention (PCI) has become a pivota...
Saved in:
Main Authors: | Guiping Wang, Kaijie Qi, Xuyang Li, Shuping Zuo, Ruolin Zhang, Yanan Zhao, Suya Sun, Juanjuan Zhang, Xiaokun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/cdr/5549914 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bivalirudin vs. Heparin on Radial Artery Thrombosis during Transradial Coronary Intervention: An Optical Coherence Tomography Study
by: Zijing Liu, et al.
Published: (2020-01-01) -
Outcomes of Percutaneous Coronary Intervention in Patients with Spontaneous Coronary Artery Dissection
by: Saber Hassan, et al.
Published: (2021-01-01) -
Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016-01-01) -
Successful Percutaneous Coronary Intervention for Atherosclerotic Coronary Lesion with Anomalous Origin of the Right Coronary Artery
by: Junji Matsuda, et al.
Published: (2018-01-01) -
The Rise of Transradial Artery Access for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes in Australia
by: Ryan James Ocsan, et al.
Published: (2020-01-01)